Public Employees Retirement System Of Ohio Aeglea Bio Therapeutics, Inc. Transaction History

Public Employees Retirement System Of Ohio

$22.6 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.5 - $2.66 $4,094 - $21,782	-8,189 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.87 - $4.77 $8,033 - $20,491	4,296 Added 110.35%	8,189 $19,000
Q4 2021 Feb 15, 2022	BUY	$3.5 - $8.42 $13,625 - $32,779	3,893 New	3,893 $18,000
Q2 2020 Aug 17, 2020	SELL	$4.01 - $11.04 $1,499 - $4,128	-374 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$3.51 - $8.48 $1,312 - $3,171	374 New	374 $2,000
Q3 2019 Nov 15, 2019	SELL	$6.42 - $9.0 $25,038 - $35,100	-3,900 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$6.1 - $8.78 $23,790 - $34,242	3,900 New	3,900 $27,000

Others Institutions Holding AGLE

# of Institutions

Shares Held

241K

Call Options Held

Put Options Held

Abingworth LLP London, X0

241K
Shares

$6.65 Million
0.04% of portfolio

View Full List

About Aeglea BioTherapeutics, Inc.

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

More about AGLE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.

Account